Deuterium Capital Management, LLC
Position in CRSP — CRISPR Therapeutics AG
CIK 1860487
Clearwater, FL
Position in CRSP
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,363,500
+$174,250 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#140
of 519 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deuterium Capital Management, LLC holds $3,055,500 across 2 Biotechnology names. CRSP ranks #2 (44.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
|
100,000 | $1,692,000 | |
| 2 | CRSP |
CRISPR Therapeutics AG
This page
|
25,000 | $1,363,500 |
All Filings in CRSP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,363,500 | 25,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,189,250 | 25,000 | Shares | Sole | 2026-05-14 | |
| 2022-03-31 | $1,129,860 | 18,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,364,040 | 18,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||